Shenzhen YHLO Biotech Co., Ltd.

SHSE:688575 Stock Report

Market Cap: CN¥9.4b

Shenzhen YHLO Biotech Future Growth

Future criteria checks 5/6

Shenzhen YHLO Biotech is forecast to grow earnings and revenue by 37.4% and 24.4% per annum respectively. EPS is expected to grow by 37.4% per annum. Return on equity is forecast to be 18.1% in 3 years.

Key information

37.4%

Earnings growth rate

37.4%

EPS growth rate

Medical Equipment earnings growth25.9%
Revenue growth rate24.4%
Future return on equity18.1%
Analyst coverage

Low

Last updated04 Dec 2024

Recent future growth updates

Recent updates

Shenzhen YHLO Biotech (SHSE:688575) Has A Pretty Healthy Balance Sheet

Nov 27
Shenzhen YHLO Biotech (SHSE:688575) Has A Pretty Healthy Balance Sheet

We Think That There Are More Issues For Shenzhen YHLO Biotech (SHSE:688575) Than Just Sluggish Earnings

Nov 06
We Think That There Are More Issues For Shenzhen YHLO Biotech (SHSE:688575) Than Just Sluggish Earnings

Slammed 25% Shenzhen YHLO Biotech Co., Ltd. (SHSE:688575) Screens Well Here But There Might Be A Catch

Nov 04
Slammed 25% Shenzhen YHLO Biotech Co., Ltd. (SHSE:688575) Screens Well Here But There Might Be A Catch

Estimating The Intrinsic Value Of Shenzhen YHLO Biotech Co., Ltd. (SHSE:688575)

Oct 31
Estimating The Intrinsic Value Of Shenzhen YHLO Biotech Co., Ltd. (SHSE:688575)

Shenzhen YHLO Biotech (SHSE:688575) Is Reinvesting At Lower Rates Of Return

Oct 12
Shenzhen YHLO Biotech (SHSE:688575) Is Reinvesting At Lower Rates Of Return

Shenzhen YHLO Biotech Co., Ltd.'s (SHSE:688575) Price In Tune With Earnings

Aug 30
Shenzhen YHLO Biotech Co., Ltd.'s (SHSE:688575) Price In Tune With Earnings

Does Shenzhen YHLO Biotech (SHSE:688575) Have A Healthy Balance Sheet?

Jul 18
Does Shenzhen YHLO Biotech (SHSE:688575) Have A Healthy Balance Sheet?

Shenzhen YHLO Biotech Co., Ltd. (SHSE:688575) Not Lagging Market On Growth Or Pricing

May 23
Shenzhen YHLO Biotech Co., Ltd. (SHSE:688575) Not Lagging Market On Growth Or Pricing

Shenzhen YHLO Biotech's (SHSE:688575) Sluggish Earnings Might Be Just The Beginning Of Its Problems

May 01
Shenzhen YHLO Biotech's (SHSE:688575) Sluggish Earnings Might Be Just The Beginning Of Its Problems

There Are Reasons To Feel Uneasy About Shenzhen YHLO Biotech's (SHSE:688575) Returns On Capital

Mar 19
There Are Reasons To Feel Uneasy About Shenzhen YHLO Biotech's (SHSE:688575) Returns On Capital

Earnings and Revenue Growth Forecasts

SHSE:688575 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20263,3207552667964
12/31/20252,678569496675
12/31/20242,137428-166835
9/30/20241,90228966735N/A
6/30/20241,938387-36613N/A
3/31/20241,824340-339359N/A
12/31/20232,053355-736-73N/A
9/30/20232,397424-333292N/A
6/30/20232,719488-214419N/A
3/31/20233,27158266663N/A
12/31/20223,9811,0121,0181,583N/A
9/30/20223,450923412933N/A
6/30/20222,967782381816N/A
3/31/20222,312678501813N/A
12/31/20211,178205-113260N/A
9/30/20211,147216-45253N/A
6/30/20211,118198-26230N/A
3/31/20211,020198-38230N/A
1/1/202199921193282N/A
12/31/2019877108-6068N/A
12/31/201872938-15730N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 688575's forecast earnings growth (37.4% per year) is above the savings rate (2.8%).

Earnings vs Market: 688575's earnings (37.4% per year) are forecast to grow faster than the CN market (25.8% per year).

High Growth Earnings: 688575's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 688575's revenue (24.4% per year) is forecast to grow faster than the CN market (13.8% per year).

High Growth Revenue: 688575's revenue (24.4% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 688575's Return on Equity is forecast to be low in 3 years time (18.1%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 23:17
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shenzhen YHLO Biotech Co., Ltd. is covered by 9 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Pei ChengChina Galaxy Securities Co., Ltd.
Shiyu ChenChina International Capital Corporation Limited
Wei SunChina Merchants Securities Co. Ltd.